1
|
Feschuk AM, Green M, Kashetsky N, Maibach HI. Pityriasis Lichenoides Following SARS-CoV-2 Infection/Vaccination. CURRENT DERMATOLOGY REPORTS 2023; 12:27-32. [PMID: 36688177 PMCID: PMC9844164 DOI: 10.1007/s13671-023-00380-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/04/2022] [Indexed: 01/19/2023]
Abstract
Purpose of Review Pityriasis lichenoides (PL) is a spectrum of dermatological conditions involving polymorphous lesions. Natural history of the condition ranges from acute to chronic. Cases of PL following SARS-CoV-2 infection/vaccination have been reported, but not yet comprehensively reviewed. Hence, the objective of this article is to review and summarize cases of PL following SARS-CoV-2 infection/vaccination in order to guide clinicians in its diagnosis and management. Recent Findings PubMed, Embase, and Web of Science were searched for relevant articles. Thirteen articles, consisting of 14 cases of PL following SARS-CoV-2 infection/vaccination, were identified. Males represented 64.3% of cases, and the average age of those affected was 41.4 years. The majority of cases (N = 9, 64.3%) were following SARS-CoV-2 vaccination, the most commonly implicated being Pfizer-BioNTech (n = 8/10, 80%), while four (28.6) followed infection. The overall latency period ranged from 5 days to 1 month. Treatments varied greatly. However, at the time of follow-up, 12/14 patients (85.7%) had either marked improvement or complete resolution of lesions. Summary This review cannot determine causality. However, a temporal association was observed with the case reports, and one case of PL followed SARS-CoV-2 infection and recurred with subsequent vaccination, suggesting an association. Nevertheless, risk of developing PL following SARS-CoV-2 infection/vaccination is likely extremely low. There is also the possibility these cases are purely coincidental. Still, clinicians should be aware of this possible etiology when diagnosing a new or exacerbated case of PL. Finally, given that the majority of patients had marked improvement or complete resolution of lesions at the time of follow-up, clinicians should provide reassurance to their affected patients.
Collapse
Affiliation(s)
- Aileen M. Feschuk
- Faculty of Medicine, Memorial University of Newfoundland, 300 Prince Philip Dr.Newfoundland & Labrador, St. John’s, A1B 3V6 Canada
| | - Maxwell Green
- Tulane University School of Medicine, New Orleans, LA USA
| | - Nadia Kashetsky
- Faculty of Medicine, Memorial University of Newfoundland, 300 Prince Philip Dr.Newfoundland & Labrador, St. John’s, A1B 3V6 Canada
| | - Howard I. Maibach
- Department of Dermatology, University of California San Francisco, San Francisco, CA USA
| |
Collapse
|
2
|
De La Garza H, Saliba E, Rosales Santillan M, Brem C, Vashi NA. Pityriasis Lichenoides et Varioliformis Acuta as a Complication of COVID-19 Infection. Dermatopathology (Basel) 2022; 9:244-250. [PMID: 35892481 PMCID: PMC9326675 DOI: 10.3390/dermatopathology9030028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2022] [Revised: 06/22/2022] [Accepted: 06/28/2022] [Indexed: 11/17/2022] Open
Abstract
Pityriasis lichenoides is an acute and/or chronic skin disease associated with recurrent erythematous papules that self-resolve. While its etiology is unknown, preceding viral infection may play a role. We present an atypical case of a 40-year-old woman with pityriasis lichenoides et varioliformis acuta as a complication of a COVID-19 infection.
Collapse
Affiliation(s)
- Henriette De La Garza
- Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA; (H.D.L.G.); (E.S.); (M.R.S.); (C.B.)
| | - Elie Saliba
- Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA; (H.D.L.G.); (E.S.); (M.R.S.); (C.B.)
- Department of Dermatology, Brown University, Providence, RI 02903, USA
| | - Monica Rosales Santillan
- Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA; (H.D.L.G.); (E.S.); (M.R.S.); (C.B.)
| | - Candice Brem
- Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA; (H.D.L.G.); (E.S.); (M.R.S.); (C.B.)
| | - Neelam A. Vashi
- Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA; (H.D.L.G.); (E.S.); (M.R.S.); (C.B.)
- Boston Health Care System, U.S. Department of Veterans Affairs, Boston, MA 02130, USA
| |
Collapse
|
3
|
Del Giudice P, Hubiche T. Disseminated febrile punctiform erythematous and petechial eruption in children - a paraviral phenomenon. J Eur Acad Dermatol Venereol 2022; 36:e887-e888. [PMID: 35690991 DOI: 10.1111/jdv.18320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2022] [Accepted: 06/03/2022] [Indexed: 11/30/2022]
Affiliation(s)
- P Del Giudice
- Infectiology and Dermatology Unit, Centre Hospitalier Intercommunal de Fréjus-Saint-Raphaël, Fréjus, France
| | - T Hubiche
- Infectiology and Dermatology Unit, Centre Hospitalier Intercommunal de Fréjus-Saint-Raphaël, Fréjus, France.,Dermatology, Centre Hospitalier Universitaire de Nice, Hôpital L'Archet, Nice, France
| |
Collapse
|
4
|
Dawoud NM, Aslam H, Ali IM, Dawoud MM. The first case report of Pityriasis lichenoides chronica following COVID-19 mRNA vaccination. Dermatol Ther 2022; 35:e15445. [PMID: 35286000 PMCID: PMC9111814 DOI: 10.1111/dth.15445] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2022] [Revised: 02/24/2022] [Accepted: 03/11/2022] [Indexed: 11/29/2022]
Affiliation(s)
- Noha Mohammed Dawoud
- Department of Dermatology, Andrology and STDs, Faculty of medicine, Menoufia University, Egypt.,Department of Dermatology, Al Hada armed forces hospital, Taif, Saudi Arabia
| | - Huma Aslam
- Department of Pathology, Fatima Jinnah medical university, Lahore, Pakistan.,Department of Histopathology, Al Hada armed forces hospital, Taif, Saudi Arabia
| | - Ishraga Mahmoud Ali
- Department of Dermatology, Al Hada armed forces hospital, Taif, Saudi Arabia
| | | |
Collapse
|
5
|
Colonna C, Restano L, Monzani N, Zussino M, Ponziani A, Cambiaghi S, Cavalli R. Rare and common manifestations of COVID-19 in children. JEADV CLINICAL PRACTICE 2022; 1:21-30. [PMID: 37829273 PMCID: PMC9088562 DOI: 10.1002/jvc2.10] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/11/2022] [Revised: 01/23/2022] [Accepted: 01/26/2022] [Indexed: 01/08/2023]
Abstract
Introduction It has been almost 2 years since the first reports on cutaneous manifestations of COVID-19. Those reported in children are different and include macular, papular, lichenoid, vesicular, urticarial, and vascular morphologies, among others. The prognosis of isolated cutaneous involvement in COVID-19 in children is usually self-limiting but the extreme variety of clinical presentations complicates the clinical approach. Methods Numerous reviews have been systematically drafted and edited giving the clinicians a future direction for skin presentations during pandemics. Results and Discussion Hereby we report the rare and common manifestations of COVID-19 in children and question the recurrence phenomena and age-related distribution of the eruptions.
Collapse
Affiliation(s)
- Cristiana Colonna
- Pediatric Dermatology UnitFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilanItaly
- Department of Clinical Sciences and Community HealthUniversità degli Studi di MilanoMilanItaly
| | - Lucia Restano
- Pediatric Dermatology UnitFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilanItaly
- Department of Clinical Sciences and Community HealthUniversità degli Studi di MilanoMilanItaly
| | - Nicola A. Monzani
- Pediatric Dermatology UnitFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilanItaly
- Department of Clinical Sciences and Community HealthUniversità degli Studi di MilanoMilanItaly
- Neonatal Intensive Care UnitFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilanItaly
| | - Martina Zussino
- Pediatric Dermatology UnitFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilanItaly
- Department of Clinical Sciences and Community HealthUniversità degli Studi di MilanoMilanItaly
| | - Alessandra Ponziani
- Pediatric Dermatology UnitFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilanItaly
- Department of Clinical Sciences and Community HealthUniversità degli Studi di MilanoMilanItaly
| | - Stefano Cambiaghi
- Pediatric Dermatology UnitFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilanItaly
- Department of Clinical Sciences and Community HealthUniversità degli Studi di MilanoMilanItaly
| | - Riccardo Cavalli
- Pediatric Dermatology UnitFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilanItaly
- Department of Clinical Sciences and Community HealthUniversità degli Studi di MilanoMilanItaly
| |
Collapse
|
6
|
Mäkilä T, Jeskanen L, Butina M, Harjama L, Ranki A, Mälkönen T, Kluger N. Pityriasis lichenoides et varioliformis acuta after SARS‐CoV‐2 infection and relapse after vaccination. J Eur Acad Dermatol Venereol 2022; 36:e431-e433. [PMID: 35184341 PMCID: PMC9114994 DOI: 10.1111/jdv.18024] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2021] [Accepted: 02/15/2022] [Indexed: 11/28/2022]
Affiliation(s)
- Tuomas Mäkilä
- Department of dermatology, allergology and venereology Helsinki University Hospital and University of Helsinki Helsinki Finland
| | - Leila Jeskanen
- Department of dermatology, allergology and venereology Helsinki University Hospital and University of Helsinki Helsinki Finland
| | - Mariia Butina
- Department of dermatology, allergology and venereology Helsinki University Hospital and University of Helsinki Helsinki Finland
| | - Liisa Harjama
- Department of dermatology, allergology and venereology Helsinki University Hospital and University of Helsinki Helsinki Finland
| | - Annamari Ranki
- Department of dermatology, allergology and venereology Helsinki University Hospital and University of Helsinki Helsinki Finland
| | - Tarja Mälkönen
- Department of dermatology, allergology and venereology Helsinki University Hospital and University of Helsinki Helsinki Finland
| | - Nicolas Kluger
- Department of dermatology, allergology and venereology Helsinki University Hospital and University of Helsinki Helsinki Finland
| |
Collapse
|
7
|
Palmén J, Lepistö M, Talve L, Hieta N. Pityriasis lichenoides et varioliformis acuta following COVID-19 mRNA vaccination. J Eur Acad Dermatol Venereol 2022; 36:e327-e328. [PMID: 35015904 DOI: 10.1111/jdv.17912] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2021] [Revised: 12/14/2021] [Accepted: 01/07/2022] [Indexed: 10/19/2022]
Affiliation(s)
- J Palmén
- Departments of Dermatology, Turku University Hospital and University of Turku, PO Box 52, FIN-20521, Turku
| | - M Lepistö
- Departments Pathology, Turku University Hospital and University of Turku, PO Box 52, FIN-20521, Turku
| | - L Talve
- Departments Pathology, Turku University Hospital and University of Turku, PO Box 52, FIN-20521, Turku
| | - N Hieta
- Departments of Dermatology, Turku University Hospital and University of Turku, PO Box 52, FIN-20521, Turku
| |
Collapse
|
8
|
Dondi A, Sperti G, Gori D, Guaraldi F, Montalti M, Parini L, Piraccini BM, Lanari M, Neri I. Epidemiology and clinical evolution of non-multisystem inflammatory syndrome (MIS-C) dermatological lesions in pediatric patients affected by SARS-CoV-2 infection: A systematic review of the literature. Eur J Pediatr 2022; 181:3577-3593. [PMID: 35948654 PMCID: PMC9365226 DOI: 10.1007/s00431-022-04585-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/09/2022] [Revised: 07/19/2022] [Accepted: 08/03/2022] [Indexed: 02/07/2023]
Abstract
UNLABELLED COVID-19 can present with a range of skin manifestations, some of which specific of the pediatric age. The aim of this systematic literature review was to determine the type, prevalence, time of onset, and evolution of cutaneous manifestations associated with COVID-19 in newborns, children, and adolescents, after excluding multisystem inflammatory syndrome in children (MIS-C). PubMed, Tripdatabase, ClinicalTrials, and Cochrane Library databases were searched using an ad hoc string for case reports/series and observational studies, published between December 2019 and February 2022. Study quality was assessed using the STROBE and CARE tools. Seventy-three (49 case reports/series and 24 studies) out of 26,545 identified articles were included in the analysis. Dermatological lesions were highly heterogeneous for clinical presentation, time of onset, and association with other COVID-19 manifestations. Overall, they mainly affected the acral portions, and typically presented a favorable outcome. Pseudo-chilblains were the most common. CONCLUSIONS Mucocutaneous manifestations could be the only/predominant and early manifestation of COVID-19 that could precede other more severe manifestations by days or weeks. Therefore, physicians of all disciplines should be familiar with them. WHAT IS KNOWN • A variety of cutaneous manifestations have been reported in association with COVID-19. • Urticaria, maculopapular, or vesicular rashes can occur at any age, while chilblains and erythema multiforme are more common in children and young patients. WHAT IS NEW • Skin lesions related to SARS-CoV-2 infection often show a peculiar acral distribution. • Mucocutaneous lesions of various type may be the only/predominant manifestation of COVID-19; they could present in paucisymptomatic and severely ill patients and occur at different stages of the disease.
Collapse
Affiliation(s)
- Arianna Dondi
- Pediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy
| | - Giacomo Sperti
- School of Pediatrics, Alma Mater Studiorum, University of Bologna, Bologna, Italy
| | - Davide Gori
- Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy
| | - Federica Guaraldi
- IRCCS Istituto Delle Scienze Neurologiche Di Bologna, 40139, Bologna, Italy.
| | - Marco Montalti
- School of Hygiene and Preventive Medicine, Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, Public Health and Medical Statistics, University of Bologna, Bologna, Italy
| | - Lorenza Parini
- School of Pediatrics, Alma Mater Studiorum, University of Bologna, Bologna, Italy
| | - Bianca Maria Piraccini
- School of Hygiene and Preventive Medicine, Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, Public Health and Medical Statistics, University of Bologna, Bologna, Italy
| | - Marcello Lanari
- Pediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy
| | - Iria Neri
- Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy
| |
Collapse
|